{"id":20768,"date":"2022-07-08T11:41:17","date_gmt":"2022-07-08T11:41:17","guid":{"rendered":"https:\/\/labs.100x100.net\/projects\/lluita\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/"},"modified":"2023-06-20T07:32:27","modified_gmt":"2023-06-20T07:32:27","slug":"roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid","status":"publish","type":"post","link":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/","title":{"rendered":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#8217;anticossos que redueix un 30% la mortalitat de la covid"},"content":{"rendered":"\r\n<p>La mortalitat per COVID-19 entre les persones que requereixen hospitalitzaci\u00f3 continua essent elevada, tot i la continuada millora en l\u2019assist\u00e8ncia cl\u00ednica i el tractament de la malaltia.<\/p>\r\n\r\n\r\n\r\n<p>Ara, un estudi internacional publicat a la revista m\u00e8dica <strong>The Lancet Respiratory<\/strong> <strong>Medicine<\/strong>, identifica una nova estrat\u00e8gia per reduir, encara m\u00e9s, aquesta mortalitat. Es tracta d\u2019afegir l\u2019antic\u00f2s monoclonal tixagevimab\/cilgavimab al tractament est\u00e0ndard amb remdesivir i dexametasona que ja s\u2019administra als hospitals. Aquest assaig cl\u00ednic de fase 3, realitzat a pacients hospitalitzats amb diferent gravetat per\u00f2 que no requerien d\u2019UCI, ha demostrat que aquesta estrat\u00e8gia \u00e9s segura i, tot i que no escur\u00e7a el per\u00edode de recuperaci\u00f3 dels pacients, s\u00ed que <strong>rebaixa un 30% la mortalitat, sobretot en aquells pacients m\u00e9s greus<\/strong>.<\/p>\r\n\r\n\r\n\r\n<p><strong>Roger Paredes<\/strong>, cap del Servei de Malalties Infeccioses de l&#8217;<a href=\"http:\/\/germanstriashospital.cat\/web\/guest\/inici\">Hospital Germans Trias i Pujol<\/a>, investigador principal de l&#8217;<a href=\"https:\/\/www.irsicaixa.es\/ca\">Institut de Recerca de la Sida IrsiCaixa<\/a> i cap de recerca de la <a href=\"https:\/\/www.lluita.org\/\">Fundaci\u00f3 Lluita contra les Infeccions<\/a>, \u00e9s un dels tres primers autors d\u2019aquest treball. Paredes \u00e9s el coordinador a Espanya de la plataforma d\u2019assajos cl\u00ednics de pacients hospitalitzats per COVID19 anomenada ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO), finan\u00e7ada pels National Institutes of Health (NIH) d\u2019EEUU. Aquesta plataforma compta amb la participaci\u00f3 d\u2019hospitals d\u2019arreu del m\u00f3n, entre el quals n\u2019hi ha cinc de Catalunya (l\u2019Hospital Germans Trias, l\u2019Hospital Cl\u00ednic, l\u2019Hospital Arnau de Vilanova, l\u2019Hospital del Mar, i l\u2019Hospital Vall d\u2019Hebron) i tres de Madrid (els hospitals Gregorio Mara\u00f1\u00f3n, La Paz i Cl\u00ednico San Carlos).<br \/><br \/>En concret, l\u2019assaig va avaluar el potencial d\u2019una dosi intravenosa \u00fanica d\u2019aquest antic\u00f2s en persones hospitalitzades, per\u00f2 que no es trobaven a la UCI, a qui tamb\u00e9 se\u2019ls administrava altres f\u00e0rmacs ja aprovats i utilitzats de forma rutin\u00e0ria, com el remdesivir o la dexametasona. De tot plegat se\u2019n va avaluar la capacitat de recuperaci\u00f3 i la mortalitat de les persones que participaven a l\u2019assaig cl\u00ednic. Tot i que els resultats no van demostrar una millora significativa de les taxes de recuperaci\u00f3, aquesta nova estrat\u00e8gia s\u00ed que va portar a una reducci\u00f3 cl\u00ednicament rellevant d\u2019un 30% de la mortalitat, sobretot en pacients m\u00e9s greus que necessitaven concentracions d\u2019oxigen m\u00e9s elevades o ventilaci\u00f3 mec\u00e0nica no invasiva. A m\u00e9s, a difer\u00e8ncia d\u2019anteriors estudis amb altres anticossos monoclonals que perdien efic\u00e0cia davant \u00f2micron, la variant predominant actualment, la combinaci\u00f3 de tixagevimab\/cilgavimab mantindria la seva capacitat de bloquejar aquesta variant del virus a les dosis administrades.<br \/><br \/><strong>Un estudi d\u2019abast mundial<\/strong><br \/>L\u2019estudi, acabat recentment, es va dur a terme a una vuitantena de centres d\u2019arreu del m\u00f3n i, a Espanya, va comptar amb la participaci\u00f3 de 150 persones ingressades a planta convencional i a unitats de semicr\u00edtics: 75 a l\u2019Hospital Germans Trias i 75 m\u00e9s a altres hospitals del pa\u00eds. Haver incl\u00f2s un gran i divers nombre de pacients d\u2019arreu del m\u00f3n \u00e9s un dels punts forts de l\u2019assaig, que suggereix que els resultats serien \u00e0mpliament generalitzables en no observar-se difer\u00e8ncies en la seva efic\u00e0cia o seguretat segons la comorbiditat, l&#8217;estat immunodeprimit, o l&#8217;estat de vacunaci\u00f3 dels pacients.<\/p>\r\n\r\n\r\n\r\n<p>L\u2019estudi s\u2019ha realitzat en coordinaci\u00f3 amb l\u2019FDA i l\u2019Ag\u00e8ncia Europea del Medicament, que avaluaran la possibilitat que aquest f\u00e0rmac esdevingui un nou tractament addicional en els propers mesos. \u201cTot aix\u00f2 ens demostra que alguns anticossos monoclonals, afegits al tractament habitual amb remdesivir i dexametasona, podrien contribu\u00eft a reduir la mortalitat per COVID-19, sobretot als pacients m\u00e9s greus.<\/p>\r\n\r\n\r\n\r\n<p>&#8220;Des de la comunitat cient\u00edfica estem avan\u00e7ant cap a l\u2019\u00fas de tractaments antivirals combinats amb l\u2019objectiu d\u2019aconseguir frenar el virus pel m\u00e0xim de vies possibles\u201d, resumeix Paredes.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Un estudi mundial liderat a nivell nacional pel metge investigador Roger Paredes mostra que afegir un nou<br \/>\nantiviral al tractament actual contra la COVID-19 podria reduir un 30% la mortalitat en pacients ingressats<\/p>\n","protected":false},"author":1,"featured_media":20766,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[264],"class_list":["post-20768","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#039;anticossos que redueix un 30% la mortalitat de la covid - Fundaci\u00f3 Lluita contra les Infeccions<\/title>\n<meta name=\"description\" content=\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#039;anticossos que redueix un 30% la mortalitat de la covid\" \/>\n<meta property=\"og:description\" content=\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/\" \/>\n<meta property=\"og:site_name\" content=\"Fundaci\u00f3 Lluita contra les Infeccions\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T11:41:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-20T07:32:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hundreds-wordpress-uploads.s3.amazonaws.com\/lluita\/uploads\/2022\/07\/roger_paredes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1160\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fundaciolluita\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fundaciolluita\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/\"},\"author\":{\"name\":\"fundaciolluita\",\"@id\":\"https:\\\/\\\/lluita.org\\\/#\\\/schema\\\/person\\\/8b246ecace866ab17ec116739984bc80\"},\"headline\":\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#8217;anticossos que redueix un 30% la mortalitat de la covid\",\"datePublished\":\"2022-07-08T11:41:17+00:00\",\"dateModified\":\"2023-06-20T07:32:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/\"},\"wordCount\":681,\"image\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lluita.org\\\/custom\\\/uploads\\\/2022\\\/07\\\/roger_paredes.jpg\",\"articleSection\":[\"COVID-19\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/\",\"url\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/\",\"name\":\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d'anticossos que redueix un 30% la mortalitat de la covid - Fundaci\u00f3 Lluita contra les Infeccions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lluita.org\\\/custom\\\/uploads\\\/2022\\\/07\\\/roger_paredes.jpg\",\"datePublished\":\"2022-07-08T11:41:17+00:00\",\"dateModified\":\"2023-06-20T07:32:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/#\\\/schema\\\/person\\\/8b246ecace866ab17ec116739984bc80\"},\"description\":\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lluita.org\\\/custom\\\/uploads\\\/2022\\\/07\\\/roger_paredes.jpg\",\"contentUrl\":\"https:\\\/\\\/lluita.org\\\/custom\\\/uploads\\\/2022\\\/07\\\/roger_paredes.jpg\",\"width\":1160,\"height\":653,\"caption\":\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lluita.org\\\/en\\\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\\\/\\\/lluita.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#8217;anticossos que redueix un 30% la mortalitat de la covid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lluita.org\\\/#website\",\"url\":\"https:\\\/\\\/lluita.org\\\/\",\"name\":\"Fundaci\u00f3 Lluita contra les Infeccions\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lluita.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lluita.org\\\/#\\\/schema\\\/person\\\/8b246ecace866ab17ec116739984bc80\",\"name\":\"fundaciolluita\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g\",\"caption\":\"fundaciolluita\"},\"sameAs\":[\"https:\\\/\\\/new.lluita.org\\\/private\\\/\"],\"url\":\"https:\\\/\\\/lluita.org\\\/en\\\/author\\\/fundaciolluita\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d'anticossos que redueix un 30% la mortalitat de la covid - Fundaci\u00f3 Lluita contra les Infeccions","description":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/","og_locale":"en_US","og_type":"article","og_title":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d'anticossos que redueix un 30% la mortalitat de la covid","og_description":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid","og_url":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/","og_site_name":"Fundaci\u00f3 Lluita contra les Infeccions","article_published_time":"2022-07-08T11:41:17+00:00","article_modified_time":"2023-06-20T07:32:27+00:00","og_image":[{"width":1160,"height":653,"url":"https:\/\/hundreds-wordpress-uploads.s3.amazonaws.com\/lluita\/uploads\/2022\/07\/roger_paredes.jpg","type":"image\/jpeg"}],"author":"fundaciolluita","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fundaciolluita","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#article","isPartOf":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/"},"author":{"name":"fundaciolluita","@id":"https:\/\/lluita.org\/#\/schema\/person\/8b246ecace866ab17ec116739984bc80"},"headline":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#8217;anticossos que redueix un 30% la mortalitat de la covid","datePublished":"2022-07-08T11:41:17+00:00","dateModified":"2023-06-20T07:32:27+00:00","mainEntityOfPage":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/"},"wordCount":681,"image":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/lluita.org\/custom\/uploads\/2022\/07\/roger_paredes.jpg","articleSection":["COVID-19"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/","url":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/","name":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d'anticossos que redueix un 30% la mortalitat de la covid - Fundaci\u00f3 Lluita contra les Infeccions","isPartOf":{"@id":"https:\/\/lluita.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#primaryimage"},"image":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/lluita.org\/custom\/uploads\/2022\/07\/roger_paredes.jpg","datePublished":"2022-07-08T11:41:17+00:00","dateModified":"2023-06-20T07:32:27+00:00","author":{"@id":"https:\/\/lluita.org\/#\/schema\/person\/8b246ecace866ab17ec116739984bc80"},"description":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid","breadcrumb":{"@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#primaryimage","url":"https:\/\/lluita.org\/custom\/uploads\/2022\/07\/roger_paredes.jpg","contentUrl":"https:\/\/lluita.org\/custom\/uploads\/2022\/07\/roger_paredes.jpg","width":1160,"height":653,"caption":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d\u2019anticossos que redueix un 30% la mortalitat de la covid"},{"@type":"BreadcrumbList","@id":"https:\/\/lluita.org\/en\/roger-paredes-lidera-un-estudi-referent-a-una-terapia-danticossos-que-redueix-un-30-la-mortalitat-de-la-covid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/lluita.org\/en\/"},{"@type":"ListItem","position":2,"name":"Roger Paredes lidera un estudi referent a una ter\u00e0pia d&#8217;anticossos que redueix un 30% la mortalitat de la covid"}]},{"@type":"WebSite","@id":"https:\/\/lluita.org\/#website","url":"https:\/\/lluita.org\/","name":"Fundaci\u00f3 Lluita contra les Infeccions","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lluita.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lluita.org\/#\/schema\/person\/8b246ecace866ab17ec116739984bc80","name":"fundaciolluita","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/18a97ff0e5d67038bad233b79246a7f922424d224871d207487c88e471e664c2?s=96&d=mm&r=g","caption":"fundaciolluita"},"sameAs":["https:\/\/new.lluita.org\/private\/"],"url":"https:\/\/lluita.org\/en\/author\/fundaciolluita\/"}]}},"_links":{"self":[{"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/posts\/20768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/comments?post=20768"}],"version-history":[{"count":1,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/posts\/20768\/revisions"}],"predecessor-version":[{"id":21260,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/posts\/20768\/revisions\/21260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/media\/20766"}],"wp:attachment":[{"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/media?parent=20768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lluita.org\/en\/wp-json\/wp\/v2\/categories?post=20768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}